Dermatology (Basel, Switzerland)
Cyclosporin for atopic dermatitis in children
Abstract
This paper details a UK consensus conference held in London in April 2000 to establish guidelines for the use of cyclosporin A for atopic dermatitis in children. It should be reserved for the severest refractory atopic dermatitis. In view of its potential toxicity, careful monitoring is mandatory, in particular blood pressure and renal function.
Source and rights
Published by Dermatology (Basel, Switzerland), 2001. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Published
- 2001
- Applies to
- 🇬🇧 United Kingdom
- Scope
- National
- Journal
- Dermatology (Basel, Switzerland)
- PubMed
- 11549791
- Added to Prognia
- 25 July 2026
More in dermatology
- Joint position statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council on routine testing for latent tuberculosis infection prior to and during treatment of psoriasis patients with interleukin 17 or interleukin 23 inhibitorsNational Psoriasis Foundation Medical Board and the International Psoriasis Council · 2026
- Generalized Pustular Psoriasis: Review and Consensus of the Psoriasis Group of the Spanish Academy of Dermatology and VenereologySpanish Academy of Dermatology and Venereology · 2026
